Renaissance Capital logo

PTHN News

US IPO Weekly Recap: Three profitable companies deliver double-digit returns

PI

Three profitable companies each traded up more than 20% this past week, while the sole biotech IPO ended flat. Radio-frequency chip maker Impinj, the week's smallest IPO, delivered the largest return (+40%). For 2016 IPOs, first-day returns (+9.0%) have now eclipsed aftermarket returns (+8.8%), with the average IPO up 19%. None of the past 10 offerings have ended their first day...read more

Patheon, an LBO'd drug manufacturer, prices IPO at $21, within the range

PTHN

Patheon, a global provider of contract drug manufacturing and development services, raised $625 million by offering 29.8 million shares at $21, within the range of $19 to $22. Patheon plans to list on the NYSE under the symbol PTHN. J.P. Morgan, Morgan Stanley, Jefferies, UBS Investment Bank, Credit Suisse, Evercore ISI and Wells Fargo Securities acted as lead managers on the deal...read more

US IPO Week Ahead: Three profitable IPOs and a biotech look to raise $900 million

PTHN

Four IPOs are on the calendar to raise nearly $900 million in the week ahead. Three are profitable, including the fourth-largest offering of 2016 and two companies that grew more than 30% in the MRQ. A biotech with heavy insider buying will also come to market, another IPO in the most...read more

US IPO Weekly Recap: LINE and AdvancePierre trade up on market debut

LN

All eyes were on Japanese messaging application LINE's (LN) highly anticipated debut this week; and it did not disappoint, popping 27% on its opening day. AdvancePierre Foods (APFH) raised $391 million and traded up 14% its first day, closing out an active week that began with five companies setting terms on Monday. With...read more